# Site TraceMap Tools Evidence Decision Record Review Packet

Status: not-started
Readiness: ready-for-implementation
Public claim level: concept

## Review Objective

Review this spec-only packet for a future `tracemap.tools` evidence decision
record page or section. The future surface should show how a team records a
human owner decision after inspecting TraceMap evidence: the question, proof
path, evidence tier, limitation, owner decision, follow-up, and non-claims.

This packet intentionally changes no site source, site scripts, scanner code,
reducer code, generated outputs, validation scripts, public copy, decision
automation, approval workflow, runtime telemetry, AI/LLM analysis, embeddings,
vector databases, or prompt classification.

TraceMap provides evidence, not the decision.

## Files In Scope

- `.kiro/specs/site-tracemap-tools-evidence-decision-record/requirements.md`
- `.kiro/specs/site-tracemap-tools-evidence-decision-record/design.md`
- `.kiro/specs/site-tracemap-tools-evidence-decision-record/tasks.md`
- `.kiro/specs/site-tracemap-tools-evidence-decision-record/implementation-state.md`
- `.kiro/specs/site-tracemap-tools-evidence-decision-record/review-packet.md`

## Reviewer Questions

1. Does the spec make clear that the future surface is concept-level and must
   visibly say `Public claim level: concept`?
2. Does it require visible `No public conclusion without evidence`?
3. Does it require visible wording that TraceMap provides evidence, not the
   decision?
4. Does it require a final placement decision and rejected alternatives for
   `/decisions/evidence-record/`, `/review-room/decision-record/`, a section
   on `/review-room/`, or a section on `/packets/assembly/`?
5. Does it distinguish the future surface from `/review-room/`,
   `/packets/assembly/`, `/review-claim-checklist/`, `/manager-packet/`,
   `/questions/objections/`, and `/proof-paths/tour/`?
6. Does it include all required record fields: decision question, decision
   owner, public claim level, proof path, rule ID/family, evidence tier,
   coverage label, commit SHA, extractor version, limitation, non-claim,
   validation evidence, rejected interpretation, follow-up owner, review date
   placeholder, and residual risk?
7. Does it include required sections: why record the decision, record
   template, example safe record, unsafe record examples, stop conditions,
   follow-up owners, and non-claims?
8. Are the future boundaries clear enough for no autonomous decision claim, no
   approval workflow claim, no release approval or safety, no runtime proof,
   no production proof, no absence-of-impact proof, no complete coverage, no
   AI/LLM analysis, and no replacement of human judgment or governance?
9. Does it prohibit raw facts, SQLite, analyzer logs, source snippets, SQL,
   config values, secrets, local paths, remotes, generated scan directories,
   private sample names, command output, hidden validation details, and
   credential-like values?
10. Does the tone guidance avoid blame language and frame rejected
    interpretations as evidence boundaries?
11. Are future validation expectations specific enough for required record
    fields, required links, metadata, discovery/sitemap metadata if
    standalone, forbidden approval and decision claims, private/raw material,
    word count bounds, and desktop/mobile browser sanity?

## Required Review Commands

Run if available:

```bash
node scripts/kiro-review.mjs --phase site-tracemap-tools-evidence-decision-record --kind spec --model claude-opus-4.8 --fresh --timeout-ms 600000 --save-review-text
node scripts/kiro-review.mjs --phase site-tracemap-tools-evidence-decision-record --kind spec --model claude-sonnet-4.6 --fresh --timeout-ms 600000 --save-review-text
```

If a model or tool is unavailable, record the exact command and error in
`implementation-state.md`.

## Review Status

Initial review and multiple reduced-coverage re-review passes ran with
`claude-opus-4.8` and `claude-sonnet-4.6`. Medium findings were patched or
converted into explicit implementation requirements. Remaining findings are
Low or residual reduced-coverage risks recorded in `implementation-state.md`.
